Brain metastases research 19902010: Pattern of citation and systematic review of highly cited articles

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Nieder, Carsten ^a,b   Grosu, Anca L ^c   Mehta, Minesh P ^d  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF FREIBURG   (Germany)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; TRASTUZUMAB;

BRAIN METASTASIS; BREAST CANCER; BREAST CARCINOMA; CANCER RADIOTHERAPY; COGNITION; DATA BASE; FOLLOW UP; HUMAN; POSTOPERATIVE CARE; PROGNOSIS; PUBLICATION; RADIOSURGERY; REVIEW; STEREOTACTIC RADIOSURGERY; SURGICAL APPROACH; SYSTEMATIC REVIEW; BIBLIOMETRICS; BRAIN TUMOR; FACTUAL DATABASE; MEDICAL RESEARCH; METASTASIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS;

BIBLIOMETRICS; BIOMEDICAL RESEARCH; BRAIN NEOPLASMS; DATABASES, FACTUAL; HUMANS; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84867802001     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/721598     Document Type: Review

References (119)

1. Langer C. J., Mehta M. P., Current management of brain metastases, with a focus on systemic options. Journal of Clinical Oncology 2005 23 25 6207 6219 2-s2.0-24944474877 10.1200/JCO.2005.03.145
2. Suh J. H., Stereotactic radiosurgery for the management of brain metastases. The New England Journal of Medicine 2010 362 12 1119 1127 2-s2.0-77950246403 10.1056/NEJMct0806951
3. Nieder C., Norum J., Stemland J. G., Dalhaug A., Resource utilization in patients with brain metastases managed with best supportive care, radiotherapy and/or surgical resection: a markov analysis. Oncology 2010 78 5-6 348 355 2-s2.0-77956077110 10.1159/000320347
4. Nieder C., Spanne O., Mehta M. P., Grosu A. L., Geinitz H., Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 2011 117 11 2505 2512 2-s2.0-79956215071 10.1002/cncr.25707
5. Kumar V., Upadhyay S., Medhi B., Impact of the impact factor in biomedical research: its use and misuse. Singapore Medical Journal 2009 50 8 752 755 2-s2.0-70349286789
6. Young N. S., Ioannidis J. P. A., Al-Ubaydli O., Why current publication practices may distort science. PLoS Medicine 2008 5 10, article e201 1418 1422 2-s2.0-55949084294 10.1371/journal.pmed.0050201
7. Kanaan Z., Galandiuk S., Abby M., Shannon K. V., Dajani D., Hicks N., Rai S. N., The value of lesser-impact-factor surgical journals as a source of negative and inconclusive outcomes reporting. Annals of Surgery 2011 253 3 619 623 2-s2.0-79951672284 10.1097/SLA.0b013e31820d9b04
8. Owlia P., Vasei M., Goliaei B., Nassiri I., Normalized impact factor (NIF): an adjusted method for calculating the citation rate of biomedical journals. Journal of Biomedical Informatics 2011 44 2 216 220 2-s2.0-79952749501 10.1016/j.jbi.2010.11.002
9. Valérie D., Gevenois P. A., Bibliometric idicators: quality masurements of sientific publication. Radiology 2010 255 2 342 351 2-s2.0-77951443903 10.1148/radiol.09090626
10. Patchell R. A., Tibbs P. A., Walsh J. W., Dempsey R. J., Maruyama Y., Kryscio R. J., Markesbery W. R., Macdonald J. S., Young B., A randomized trial of surgery in the treatment of single metastases to the brain. The New England Journal of Medicine 1990 322 8 494 500 2-s2.0-0025189608 (Pubitemid 20067825)
11. Gaspar L., Scott C., Rotman M., Asbell S., Phillips T., Wasserman T., McKenna W. G., Byhardt R., Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. International Journal of Radiation Oncology Biology Physics 1997 37 4 745 751 2-s2.0-0030973660 10.1016/S0360-3016(96)00619-0 (Pubitemid 27181303)
12. Andrews D. W., Scott C. B., Sperduto P. W., Flanders A. E., Gaspar L. E., Schell M. C., Werner-Wasik M., Demas W., Ryu J., Bahary J. P., Souhami L., Rotman M., Mehta M. P., Curran W. J., Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. The Lancet 2004 363 9422 1665 1672 2-s2.0-2442713678 10.1016/S0140-6736(04)16250-8 (Pubitemid 38670323)
13. Patchell R. A., Tibbs P. A., Regine W. F., Dempsey R. J., Mohiuddin M., Kryscio R. J., Markesbery W. R., Foon K. A., Young B., Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Journal of the American Medical Association 1998 280 17 1485 1489 2-s2.0-0032483685 10.1001/jama.280.17.1485 (Pubitemid 28507400)
14. Flickinger J. C., Kondziolka D., Lunsford L. D., Coffey R. J., Goodman M. L., Shaw E. G., Hudgins W. R., Weiner R., Harsh G. R., Sneed P. K., Larson D. A., A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. International Journal of Radiation Oncology Biology Physics 1994 28 4 797 802 2-s2.0-0028334970 (Pubitemid 24099860)
15. Kondziolka D., Patel A., Lunsford L. D., Kassam A., Flickinger J. C., Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. International Journal of Radiation Oncology Biology Physics 1999 45 2 427 434 2-s2.0-0032873920 10.1016/S0360-3016(99)00198-4 (Pubitemid 29408559)
16. Vecht C. J., Haaxma-Reiche H., Noordijk E. M., Padberg G. W., Voormolen J. H. C., Hoekstra F. H., Tans J. T. J., Lambooij N., Metsaars J. A. L., Wattendorff A. R., Brand R., Hermans J., Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Annals of Neurology 1993 33 6 583 590 2-s2.0-0027217452 10.1002/ana.410330605 (Pubitemid 23161878)
17. Alexander E. III, Moriarty T. M., Davis R. B., Wen P. Y., Fine H. A., Black P. M., Kooy H. M., Loeffler J. S., Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. Journal of the National Cancer Institute 1995 87 1 34 40 2-s2.0-0028909066
18. Noordijk E. M., Vecht C. J., Haaxma-Reiche H., Padberg G. W., Voormolen J. H. C., Hoekstra F. H., Tans J. T. J., Lambooij N., Metsaars J. A. L., Wattendorff A. R., Brand R., Hermans J., The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. International Journal of Radiation Oncology Biology Physics 1994 29 4 711 717 2-s2.0-0027953825 (Pubitemid 24241310)
19. Mintz A. H., Kestle J., Rathbone M. P., A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996 78 1470 1476 (Pubitemid 26317868)
20. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., Kenjyo M., Oya N., Hirota S., Shioura H., Kunieda E., Inomata T., Hayakawa K., Katoh N., Kobashi G., Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. Journal of the American Medical Association 2006 295 21 2483 2491 2-s2.0-33744954692 10.1001/jama.295.21.2483 (Pubitemid 43854963)
21. Bos P. D., Zhang X. H. F., Nadal C., Shu W., Gomis R. R., Nguyen D. X., Minn A. J., Van De Vijver M. J., Gerald W. L., Foekens J. A., Massagué J., Genes that mediate breast cancer metastasis to the brain. Nature 2009 459 7249 1005 1009 2-s2.0-67649300721 10.1038/nature08021
22. Bendell J. C., Domchek S. M., Burstein H. J., Harris L., Younger J., Kuter I., Bunnell C., Rue M., Gelman R., Winer E., Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 2003 97 12 2972 2977 2-s2.0-0038010542 10.1002/cncr.11436 (Pubitemid 36676250)
23. Lin N. U., Diéras V., Paul D., Lossignol D., Christodoulou C., Stemmler H. J., Roché H., Liu M. C., Greil R., Ciruelos E., Loibl S., Gori S., Wardley A., Yardley D., Brufsky A., Blum J. L., Rubin S. D., Dharan B., Steplewski K., Zembryki D., Oliva C., Roychowdhury D., Paoletti P., Winer E. P., Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clinical Cancer Research 2009 15 4 1452 1459 2-s2.0-63149110733 10.1158/1078-0432.CCR-08-1080
24. Chang E. L., Wefel J. S., Hess K. R., Allen P. K., Lang F. F., Kornguth D. G., Arbuckle R. B., Swint J. M., Shiu A. S., Maor M. H., Meyers C. A., Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. The Lancet Oncology 2009 10 11 1037 1044 2-s2.0-71249157772 10.1016/S1470-2045(09) 70263-3
25. Lin N. U., Carey L. A., Liu M. C., Younger J., Come S. E., Ewend M., Harris G. J., Bullitt E., Van Den Abbeele A. D., Henson J. W., Li X., Gelman R., Burstein H. J., Kasparian E., Kirsch D. G., Crawford A., Hochberg F., Winer E. P., Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. Journal of Clinical Oncology 2008 26 12 1993 1999 2-s2.0-42949112556 10.1200/JCO.2007.12.3588
26. Jacquillat C., Khayat D., Banzet P., Weil M., Fumoleau P., Avril M. F., Namer M., Bonneterre J., Kerbrat P., Bonerandi J. J., Bugat R., Montcuquet P., Cupissol D., Lauvin R., Vilmer C., Prache C., Bizzari J. P., Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer 1990 66 9 1873 1878 2-s2.0-0025109821 (Pubitemid 20385954)
27. Loeffler J. S., Kooy H. M., Wen P. Y., Fine H. A., Cheng C. W., Mannarino E. G., Tsai J. S., Alexander E., The treatment of recurrent brain metastases with stereotactic radiosurgery. Journal of Clinical Oncology 1990 8 4 276 582 2-s2.0-0025412539 (Pubitemid 20127237)
28. Brega K., Robinson W. A., Winston K., Wittenberg W., Surgical treatment of brain metastases in malignant melanoma. Cancer 1990 66 2105 2110
29. Twelves C. J., Souhami R. L., Harper P. G., Ash C. M., Spiro S. G., Earl H. M., Tobias J. S., Quinn H., Geddes D. M., The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. British Journal of Cancer 1990 61 1 147 150 2-s2.0-0025177393 (Pubitemid 20043562)
30. Zhang R. D., Fidler I. J., Price J. E., Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion and Metastasis 1991 11 4 204 215 2-s2.0-0026351389
31. Davis P. C., Hudgins P. A., Peterman S. B., Hoffman J. C. Jr., Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. American Journal of Neuroradiology 1991 12 2 293 300 2-s2.0-0025975088
32. Coffey R. J., Flickinger J. C., Bissonette D. J., Lunsford L. D., Radiosurgery for solitary brain metastases using the cobalt-60 gamma unit: methods and results in 24 patients. International Journal of Radiation Oncology Biology Physics 1991 20 6 1287 1295 2-s2.0-0025900761
33. Ushio Y., Arita N., Hayakawa T., Mogami H., Hasegawa H., Bitoh S., Oku Y., Ikeda H., Kanai N., Kanoh M., Akagi K., Nakagawa H., Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery 1991 28 2 201 205 2-s2.0-0026081361
34. Patchell R. A., Brain metastases. Neurologic Clinics 1991 9 4 817 824 2-s2.0-0025937369
35. Mehta M. P., Rozental J. M., Levin A. B., Mackie T. R., Kubsad S. S., Gehring M. A., Kinsella T. J., Defining the role of radiosurgery in the management of brain metastases. International Journal of Radiation Oncology Biology Physics 1992 24 4 619 625 2-s2.0-0026465548
36. Posner J. B., Management of brain metastases. Revue Neurologique 1992 148 6-7 477 487 2-s2.0-0026740568
37. Adler J. R., Cox R. S., Kaplan I., Martin D. P., Stereotactic radiosurgical treatment of brain metastases. Journal of Neurosurgery 1992 76 3 444 449 2-s2.0-0026509458
38. Fuller B. G., Kaplan I. D., Adler J., Cox R. S., Bagshaw M. A., Stereotaxic radiosurgery for brain metastases: the importance of adjuvant whole brain irradiation. International Journal of Radiation Oncology Biology Physics 1992 23 2 413 418 2-s2.0-0026650804
39. Boogerd W., Dalesio O., Bais E. M., van der Sande J. J., Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992 69 4 972 980 2-s2.0-0026558391
40. Bindal R. K., Sawaya R., Leavens M. E., Lee J. J., Surgical treatment of multiple brain metastases. Journal of Neurosurgery 1993 79 2 210 216 2-s2.0-0027279696 (Pubitemid 23215837)
41. Engenhart R., Kimmig B. N., Hover K. H., Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 1993 71 1353 1361 (Pubitemid 23054931)
42. Somaza S., Kondziolka D., Lunsford L. D., Kirkwood J. M., Flickinger J. C., Stereotactic radiosurgery for cerebral metastatic melanoma. Journal of Neurosurgery 1993 79 5 661 666 2-s2.0-0027422227 (Pubitemid 23320882)
43. Kihlstrom L., Karlsson B., Lindquist C., Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotactic and Functional Neurosurgery 1993 61 supplement 1 45 50 2-s2.0-0027738474 (Pubitemid 24032056)
44. Vecht C. J., Hovestadt A., Verbiest H. B. C., van Vliet J. J., van Putten W. L. J., Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology 1994 44 4 675 680 2-s2.0-0028287189 (Pubitemid 24129996)
45. Strugar J., Rothbart D., Harrington W., Criscuolo G. R., Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. Journal of Neurosurgery 1994 81 4 560 566 2-s2.0-0028064746 (Pubitemid 24303282)
46. Schiff D., DeAngelis L. M., Therapy of venous thromboembolism in patients with brain metastases. Cancer 1994 73 2 493 498 2-s2.0-0028038996 (Pubitemid 24030634)
47. Wronski M., Arbit E., Burt M., Galicich J. H., Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. Journal of Neurosurgery 1995 83 4 605 616 2-s2.0-0029131199
48. Rutigliano M. J., Lunsford L. D., Kondziolka D., Strauss M. J., Khanna V., Green M., Patterson R. H., Taub E., Friedman W. A., Ciric I., The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 1995 37 3 445 455 2-s2.0-0029129002
49. Sijens P. E., Knopp M. V., Brunetti A., Wicklow K., Alfano B., Bachert P., Sanders J. A., Stillman A. E., Kett H., Sauter R., Oudkerk M., 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magnetic Resonance in Medicine 1995 33 6 818 826 2-s2.0-0028989173 10.1002/mrm.1910330612
50. Phillips T. L., Scott C. B., Leibel S. A., Rotman M., Weigensberg I. J., Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. International Journal of Radiation Oncology Biology Physics 1995 33 2 339 348 2-s2.0-0029114147 10.1016/0360-3016(95)00168-X
51. Yuh W. T. C., Tali E. T., Nguyen H. D., Simonson T. M., Mayr N. A., Fisher D. J., The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. American Journal of Neuroradiology 1995 16 2 373 380 2-s2.0-0028877763
52. Bindal R. K., Sawaya R., Leavens M. E., Hess K. R., Taylor S. H., Reoperation for recurrent metastatic brain tumors. Journal of Neurosurgery 1995 83 4 600 604 2-s2.0-0029095511
53. Nussbaum E. S., Djalilian H. R., Cho K. H., Hall W. A., Brain metastases: histology, multiplicity, surgery, and survival. Cancer 1996 78 1781 1788
54. Bindal A. K., Bindal R. K., Hess K. R., Shiu A., Hassenbusch S. J., Shi W. M., Sawaya R., Surgery versus radiosurgery in the treatment of brain metastasis. Journal of Neurosurgery 1996 84 5 748 754 2-s2.0-0029876197 (Pubitemid 26120088)
55. Joseph J., Adler J. R., Cox R. S., Hancock S. L., Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. Journal of Clinical Oncology 1996 14 4 1085 1092 2-s2.0-0029960083 (Pubitemid 26105513)
56. Shaw E., Scott C., Souhami L., Dinapoli R., Bahary J. P., Kline R., Wharam M., Schultz C., Davey P., Loeffler J., Del Rowe J., Marks L., Fisher B., Shin K., Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of Radiation Therapy Oncology Group protocol 90-05. International Journal of Radiation Oncology Biology Physics 1996 34 3 647 654 2-s2.0-0030060744 10.1016/0360-3016(95)02106-X (Pubitemid 26069194)
57. Shiau C. Y., Sneed P. K., Shu H. K. G., Lamborn K. R., McDermott M. W., Chang S., Nowak P., Petti P. L., Smith V., Verhey L. J., Ho M., Park E., Wara W. M., Gutin P. H., Larson D. A., Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. International Journal of Radiation Oncology Biology Physics 1997 37 2 375 383 2-s2.0-0030939114 10.1016/S0360-3016(96)00497-X (Pubitemid 27138722)
58. Murray K. J., Scott C., Greenberg H. M., Emami B., Seider M., Vora N. L., Olson C., Whitton A., Movsas B., Curran W., A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. International Journal of Radiation Oncology Biology Physics 1997 39 3 571 574 2-s2.0-18744420820 10.1016/S0360-3016(97)00341-6 (Pubitemid 27441421)
59. Breneman J. C., Warnick R. E., Albright R. E. Jr., Stereotactic radiosurgery for the treatment of brain metastases: results of a single institution series. Cancer 1997 79 551 557 (Pubitemid 27051781)
60. Chiu A. C., Delpassand E. S., Sherman S. I., Prognosis and treatment of brain metastases in thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1997 82 11 3637 3642 2-s2.0-0030664131 (Pubitemid 27509349)
61. Mori Y., Kondziolka D., Flickinger J. C., Kirkwood J. M., Agarwala S., Lunsford L. D., Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. International Journal of Radiation Oncology Biology Physics 1998 42 3 581 589 2-s2.0-0031724145 10.1016/S0360-3016(98)00272-7 (Pubitemid 28501108)
62. Toda M., Rabkin S. D., Martuza R. L., Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Human Gene Therapy 1998 9 15 2177 2185 2-s2.0-0032505773 (Pubitemid 28498004)
63. Mori Y., Kondziolka D., Flickinger J. C., Logan T., Lunsford L. D., Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 1998 83 344 353 (Pubitemid 28317815)
64. Agboola O., Benoit B., Cross P., Da Silva V., Esche B., Lesiuk H., Gonsalves C., Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. International Journal of Radiation Oncology Biology Physics 1998 42 1 155 159 2-s2.0-0031671478 10.1016/S0360-3016(98)00198-9 (Pubitemid 28435608)
65. Lagerwaard F. J., Levendag P. C., Nowak P. J. C. M., Eijkenboom W. M. H., Hanssens P. E. J., Schmitz P. I. M., Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. International Journal of Radiation Oncology Biology Physics 1999 43 4 795 803 2-s2.0-0033054670 10.1016/S0360-3016(98)00442-8 (Pubitemid 29152652)
66. Muacevic A., Kreth F. W., Horstmann G. A., Schmid-Elsaesser R., Wowra B., Steiger H. J., Reulen H. J., Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. Journal of Neurosurgery 1999 91 1 35 43 2-s2.0-0032696963
67. Franciosi V., Cocconi G., Michiara M., Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer 1999 85 1599 1605 (Pubitemid 29152834)
68. Lavine S. D., Petrovich Z., Cohen-Gadol A. A., Masri L. S., Morton D. L., O'Day S. J., Essner R., Zelman V., Yu C., Luxton G., Apuzzo M. L. J., Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999 44 1 59 66 2-s2.0-0032934106 10.1097/00006123-199901000-00031 (Pubitemid 29016167)
69. Shaw E., Scott C., Souhami L., Dinapoli R., Kline R., Loeffler J., Farnan N., Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90- 05. International Journal of Radiation Oncology Biology Physics 2000 47 2 291 298 2-s2.0-0034194397 10.1016/S0360-3016(99)00507-6 (Pubitemid 30236367)
70. Gaspar L. E., Scott C., Murray K., Curran W., Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. International Journal of Radiation Oncology Biology Physics 2000 47 4 1001 1006 2-s2.0-0034237213 10.1016/S0360-3016(00)00547-2 (Pubitemid 30345599)
71. Tsuda H., Takarabe T., Hasegawa F., Fukutomi T., Hirohashi S., Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. American Journal of Surgical Pathology 2000 24 2 197 202 2-s2.0-0033952627 10.1097/00000478-200002000-00005 (Pubitemid 30078708)
72. Nieder C., Nestle U., Motaref B., Walter K., Niewald M., Schnabel K., Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? International Journal of Radiation Oncology Biology Physics 2000 46 2 297 302 2-s2.0-0033959177 10.1016/S0360-3016(99)00416-2 (Pubitemid 30067778)
73. Wroski M., Arbit E., Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. Journal of Neurosurgery 2000 93 1 9 18 2-s2.0-0343953568 (Pubitemid 30457317)
74. Sanghavi S. N., Miranpuri S. S., Chappell R., Buatti J. M., Sneed P. K., Suh J. H., Regine W. F., Weltman E., King V. J., Goetsch S. J., Breneman J. C., Sperduto P. W., Scott C., Mabanta S., Mehta M. P., Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. International Journal of Radiation Oncology Biology Physics 2001 51 2 426 434 2-s2.0-0035479212 10.1016/S0360-3016(01)01622-4 (Pubitemid 32884288)
75. Abrey L. E., Olson J. D., Raizer J. J., Mack M., Rodavitch A., Boutros D. Y., Malkin M. G., A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. Journal of Neuro-Oncology 2001 53 3 259 265 2-s2.0-0034763862 10.1023/A:1012226718323 (Pubitemid 33034677)
76. Christodoulou C., Bafaloukos D., Kosmidis P., Samantas E., Bamias A., Papakostas P., Karabelis A., Bacoyiannis C., Skarlos D. V., Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Annals of Oncology 2001 12 2 249 254 2-s2.0-0035100919 10.1023/A:1008354323167 (Pubitemid 32223877)
77. Carde P., Timmerman R., Mehta M. P., Koprowski C. D., Ford J., Tishler R. B., Miles D., Miller R. A., Renschler M. F., Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. Journal of Clinical Oncology 2001 19 7 2074 2083 2-s2.0-0035300617 (Pubitemid 32702553)
78. Robinet G., Thomas P., Breton J. L., Léna H., Gouva S., Dabouis G., Bennouna J., Souquet P. J., Balmes P., Thiberville L., Fournel P., Quoix E., Riou R., Rebattu P., Pérol M., Paillotin D., Mornex F., Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) protocol 95-1. Annals of Oncology 2001 12 1 59 67 2-s2.0-0035137984 10.1023/A:1008338312647 (Pubitemid 32162449)
79. Antonadou D., Paraskevaidis M., Sarris G., Coliarakis N., Economou I., Karageorgis P., Throuvalas N., Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. Journal of Clinical Oncology 2002 20 17 3644 3650 2-s2.0-0036731532 10.1200/JCO.2002.04.140 (Pubitemid 34983224)
80. Fidler I. J., Yano S., Zhang R. D., Fujimaki T., Bucana C. D., The seed and soil hypothesis: vascularisation and brain metastases. The Lancet Oncology 2002 3 1 53 57 2-s2.0-0036161382 10.1016/S1470-2045(01)00622-2 (Pubitemid 34121146)
81. Soffietti R., Ruda R., Mutani R., Management of brain metastases. Journal of Neurology 2002 249 10 1357 1369 2-s2.0-0036405461 10.1007/s00415-002-0870-6 (Pubitemid 35217656)
82. Mehta M. P., Shapiro W. R., Glantz M. J., Patchell R. A., Weitzner M. A., Meyers C. A., Schultz C. J., Roa W. H., Leibenhaut M., Ford J., Curran W., Phan S., Smith J. A., Miller R. A., Renschler M. F., Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. Journal of Clinical Oncology 2002 20 16 3445 3453 2-s2.0-0037102391 10.1200/JCO.2002.07.500
83. Regine W. F., Huhn J. L., Patchell R. A., Clair W. H. S., Strottmann J., Meigooni A., Sanders M., Young A. B., Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagonised brain metastases: results and implications. International Journal of Radiation Oncology Biology Physics 2002 52 2 333 338 2-s2.0-0036471049 10.1016/S0360-3016(01)02645-1 (Pubitemid 34172998)
84. Mehta M. P., Rodrigus P., Terhaard C. H. J., Rao A., Suh J., Roa W., Souhami L., Bezjak A., Leibenhaut M., Komaki R., Schultz C., Timmerman R., Curran W., Smith J., Phan S. C., Miller R. A., Renschler M. F., Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. Journal of Clinical Oncology 2003 21 13 2529 2536 2-s2.0-0037676125 10.1200/JCO.2003.12.122 (Pubitemid 46606335)
85. Lu S., Ahn D., Johnson G., Cha S., Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. American Journal of Neuroradiology 2003 24 5 937 941 2-s2.0-0037503015 (Pubitemid 36617427)
86. Patchell R. A., The management of brain metastases. Cancer Treatment Reviews 2003 29 6 533 540 2-s2.0-0242392011 10.1016/S0305-7372(03)00105-1 (Pubitemid 37428325)
87. O'Neill B. P., Iturria N. J., Link M. J., Pollock B. E., Ballman K. V., O'Fallon J. R., A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. International Journal of Radiation Oncology Biology Physics 2003 55 5 1169 1176 2-s2.0-0037376828 10.1016/S0360-3016(02)04379-1 (Pubitemid 36338280)
88. Clayton A. J., Danson S., Jolly S., Ryder W. D. J., Burt P. A., Stewart A. L., Wilkinson P. M., Welch R. S., Magee B., Wilson G., Howell A., Wardley A. M., Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. British Journal of Cancer 2004 91 4 639 643 2-s2.0-4344691784 (Pubitemid 39141617)
89. Meyers C. A., Smith J. A., Bezjak A., Mehta M. P., Liebmann J., Illidge T., Kunkler I., Caudrelier J. M., Eisenberg P. D., Meerwaldt J., Siemers R., Carrie C., Gaspar L. E., Curran W., Phan S. C., Miller R. A., Renschler M. F., Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. Journal of Clinical Oncology 2004 22 1 157 165 2-s2.0-3042787102 10.1200/JCO.2004.05.128 (Pubitemid 41095128)
90. Lin N. U., Bellon J. R., Winer E. P., CNS metastases in breast cancer. Journal of Clinical Oncology 2004 22 17 3608 3617 2-s2.0-4444309646 10.1200/JCO.2004.01.175 (Pubitemid 41103668)
91. Barnholtz-Sloan J. S., Sloan A. E., Davis F. G., Vigneau F. D., Lai P., Sawaya R. E., Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. Journal of Clinical Oncology 2004 22 14 2865 2872 2-s2.0-4344694453 10.1200/JCO.2004.12. 149 (Pubitemid 41079905)
92. Mehta M. P., Tsao M. N., Whelan T. J., Morris D. E., Hayman J. A., Flickinger J. C., Mills M., Rogers C. L., Souhami L., The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. International Journal of Radiation Oncology Biology Physics 2005 63 1 37 46 2-s2.0-26944455631 10.1016/j.ijrobp.2005.05.023 (Pubitemid 41583540)
93. Weil R. J., Palmieri D. C., Bronder J. L., Stark A. M., Steeg P. S., Breast cancer metastasis to the central nervous system. American Journal of Pathology 2005 167 4 913 920 2-s2.0-26244462371 (Pubitemid 41416243)
94. Chiu C. H., Tsai C. M., Chen Y. M., Chiang S. C., Liou J. L., Perng R. P., Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity. Lung Cancer 2005 47 1 129 138 2-s2.0-10444237217 10.1016/j.lungcan.2004.05.014 (Pubitemid 39643250)
95. Verger E., Gil M., Yaya R., Viñolas N., Villà S., Pujol T., Quintó L., Graus F., Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. International Journal of Radiation Oncology Biology Physics 2005 61 1 185 191 2-s2.0-11144350196 10.1016/j.ijrobp.2004.04.061 (Pubitemid 40039121)
96. Stark A. M., Tongers K., Maass N., Mehdorn H. M., Held-Feindt J., Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. Journal of Cancer Research and Clinical Oncology 2005 131 3 191 198 2-s2.0-12944322207 10.1007/s00432-004-0629-9 (Pubitemid 40175014)
97. Khuntia D., Brown P., Li J., Mehta M. P., Whole-brain radiotherapy in the management of brain metastasis. Journal of Clinical Oncology 2006 24 8 1295 1304 2-s2.0-33644850757 10.1200/JCO.2005.04.6185 (Pubitemid 46622033)
98. Hicks D. G., Short S. M., Prescott N. L., Tarr S. M., Coleman K. A., Yoder B. J., Crowe J. P., Choueiri T. K., Dawson A. E., Budd G. T., Tubbs R. R., Casey G., Weil R. J., Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. American Journal of Surgical Pathology 2006 30 9 1097 1104 2-s2.0-33748040055 10.1097/01.pas.0000213306.05811.b9 (Pubitemid 44299342)
99. Tham Y. L., Sexton K., Kramer R., Hilsenbeck S., Elledge R., Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006 107 4 696 704 2-s2.0-33747163007 10.1002/cncr.22041 (Pubitemid 44232661)
100. Gabos Z., Sinha R., Hanson J., Chauhan N., Hugh J., Mackey J. R., Abdulkarim B., Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. Journal of Clinical Oncology 2006 24 36 5658 5663 2-s2.0-34247346051 10.1200/JCO.2006.07.0250 (Pubitemid 46631306)
101. Lin N. U., Winer E. P., Brain metastases: the HER2 paradigm. Clinical Cancer Research 2007 13 6 1648 1655 2-s2.0-34250174543 10.1158/1078-0432.CCR-06- 2478 (Pubitemid 46952930)
102. Aoyama H., Tago M., Kato N., Toyoda T., Kenjyo M., Hirota S., Shioura H., Inomata T., Kunieda E., Hayakawa K., Nakagawa K., Kobashi G., Shirato H., Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. International Journal of Radiation Oncology Biology Physics 2007 68 5 1388 1395 2-s2.0-34547427370 10.1016/j.ijrobp.2007.03.048 (Pubitemid 47176822)
103. Stemmler H. J., Schmitt M., Willems A., Bernhard H., Harbeck N., Heinemann V., Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anti-Cancer Drugs 2007 18 1 23 28 2-s2.0-33845599378 10.1097/01.cad.0000236313.50833.ee (Pubitemid 44949792)
104. Li J., Bentzen S. M., Renschler M., Mehta M. P., Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. Journal of Clinical Oncology 2007 25 10 1260 1266 2-s2.0-34247126091 10.1200/JCO.2006.09.2536 (Pubitemid 46640573)
105. Eichler A. F., Loeffler J. S., Multidisciplinary management of brain metastases. Oncologist 2007 12 7 884 898 2-s2.0-34548259259 10.1634/ theoncologist.12-7-884 (Pubitemid 47328231)
106. Sperduto P. W., Berkey B., Gaspar L. E., Mehta M., Curran W., A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. International Journal of Radiation Oncology Biology Physics 2008 70 2 510 514 2-s2.0-38149075264 10.1016/j.ijrobp.2007.06.074
107. Gril B., Palmieri D., Bronder J. L., Herring J. M., Vega-Valle E., Feigenbaum L., Liewehr D. J., Steinberg S. M., Merino M. J., Rubin S. D., Steeg P. S., Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. Journal of the National Cancer Institute 2008 100 15 1092 1103 2-s2.0-49449112267 10.1093/jnci/djn216
108. Muacevic A., Wowra B., Siefert A., Tonn J. C., Steiger H. J., Kreth F. W., Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. Journal of Neuro-Oncology 2008 87 3 299 307 2-s2.0-48049113523 10.1007/s11060-007-9510-4
109. Pouessel D., Culine S., High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. European Urology 2008 53 2 376 381 2-s2.0-37349055147 10.1016/j.eururo.2007.08. 053 (Pubitemid 350296582)
110. Socinski M. A., Langer C. J., Huang J. E., Kolb M. M., Compton P., Wang L., Akerley W., Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases. Journal of Clinical Oncology 2009 27 31 5255 5261 2-s2.0-70449725036 10.1200/JCO.2009.22.0616
111. Mehta M. P., Shapiro W. R., Phan S. C., Gervais R., Carrie C., Chabot P., Patchell R. A., Glantz M. J., Recht L., Langer C., Sur R. K., Roa W. H., Mahe M. A., Fortin A., Nieder C., Meyers C. A., Smith J. A., Miller R. A., Renschler M. F., Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. International Journal of Radiation Oncology Biology Physics 2009 73 4 1069 1076 2-s2.0-61549104698 10.1016/j.ijrobp.2008.05.068
112. Kienast Y., von Baumgarten L., Fuhrmann M., Klinkert W. E. F., Goldbrunner R., Herms J., Winkler F., Real-time imaging reveals the single steps of brain metastasis formation. Nature Medicine 2010 16 1 116 122 2-s2.0-73849129203 10.1038/nm.2072
113. Linskey M. E., Andrews D. W., Asher A. L., Burri S. H., Kondziolka D., Robinson P. D., Ammirati M., Cobbs C. S., Gaspar L. E., Loeffler J. S., McDermott M., Mehta M. P., Mikkelsen T., Olson J. J., Paleologos N. A., Patchell R. A., Ryken T. C., Kalkanis S. N., The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology 2010 96 1 45 68 2-s2.0-74949144656 10.1007/s11060-009-0073-4
114. Gaspar L. E., Mehta M. P., Patchell R. A., Burri S. H., Robinson P. D., Morris R. E., Ammirati M., Andrews D. W., Asher A. L., Cobbs C. S., Kondziolka D., Linskey M. E., Loeffler J. S., McDermott M., Mikkelsen T., Olson J. J., Paleologos N. A., Ryken T. C., Kalkanis S. N., The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology 2010 96 1 17 32 2-s2.0-75049084451 10.1007/s11060-009-0060-9
115. Kalkanis S. N., Kondziolka D., Gaspar L. E., Burri S. H., Asher A. L., Cobbs C. S., Ammirati M., Robinson P. D., Andrews D. W., Loeffler J. S., McDermott M., Mehta M. P., Mikkelsen T., Olson J. J., Paleologos N. A., Patchell R. A., Ryken T. C., Linskey M. E., The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology 2010 96 1 33 43 2-s2.0-75049083726 10.1007/s11060-009-0061-8
116. Mehta M. P., Paleologos N. A., Mikkelsen T., Robinson P. D., Ammirati M., Andrews D. W., Asher A. L., Burri S. H., Cobbs C. S., Gaspar L. E., Kondziolka D., Linskey M. E., Loeffler J. S., McDermott M., Olson J. J., Patchell R. A., Ryken T. C., Kalkanis S. N., The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology 2010 96 1 71 83 2-s2.0-75049084643 10.1007/s11060-009-0062-7
117. Figg W. D., Dunn L., Liewehr D. J., Steinberg S. M., Thurman P. W., Barrett J. C., Birkinshaw J., Scientific collaboration results in higher citation rates of published articles. Pharmacotherapy 2006 26 6 759 767 2-s2.0-33744459743 10.1592/phco.26.6.759 (Pubitemid 43807627)
118. Stringer M. J., Sales-Pardo M., Amaral L. A. N., Effectiveness of journal ranking schemes as a tool for locating information. PLoS ONE 2008 3 2 2-s2.0-45949097418 10.1371/journal.pone.0001683 e1683 (Pubitemid 351891075)
119. Stringer M. J., Sales-Pardo M., Nunes Amaral L. A., Statistical validation of a global model for the distribution of the ultimate number of citations accrued by papers published in a scientific journal. Journal of the American Society for Information Science and Technology 2010 61 7 1377 1385 2-s2.0-77954045879 10.1002/asi.21335